OLIPASS (Korea) Performance
| 244460 Stock | KRW 4,795 95.00 2.02% |
The company holds a Beta of -0.0276, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning OLIPASS are expected to decrease at a much lower rate. During the bear market, OLIPASS is likely to outperform the market. At this point, OLIPASS has a negative expected return of -0.54%. Please make sure to check OLIPASS's downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to decide if OLIPASS performance from the past will be repeated at future time.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days OLIPASS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Total Cashflows From Investing Activities | -21.1 B |
OLIPASS |
OLIPASS Relative Risk vs. Return Landscape
If you would invest 650,000 in OLIPASS on August 26, 2024 and sell it today you would lose (170,500) from holding OLIPASS or give up 26.23% of portfolio value over 90 days. OLIPASS is generating negative expected returns and assumes 5.4863% volatility on return distribution over the 90 days horizon. Simply put, 48% of stocks are less volatile than OLIPASS, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
OLIPASS Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for OLIPASS's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as OLIPASS, and traders can use it to determine the average amount a OLIPASS's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0981
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 244460 |
Estimated Market Risk
| 5.49 actual daily | 48 52% of assets are more volatile |
Expected Return
| -0.54 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average OLIPASS is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of OLIPASS by adding OLIPASS to a well-diversified portfolio.
OLIPASS Fundamentals Growth
OLIPASS Stock prices reflect investors' perceptions of the future prospects and financial health of OLIPASS, and OLIPASS fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on OLIPASS Stock performance.
| Return On Equity | -104.92 | |||
| Return On Asset | -0.24 | |||
| Operating Margin | (8.28) % | |||
| Current Valuation | 301.89 B | |||
| Revenue | 851.78 M | |||
| EBITDA | (20.48 B) | |||
| Cash And Equivalents | 8.66 B | |||
| Total Debt | 1.99 B | |||
| Debt To Equity | 0.49 % | |||
| Cash Flow From Operations | (19.62 B) | |||
| Total Asset | 46.06 B | |||
About OLIPASS Performance
By analyzing OLIPASS's fundamental ratios, stakeholders can gain valuable insights into OLIPASS's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if OLIPASS has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if OLIPASS has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
OLIPASS Corporation focuses on developing therapeutic products in South Korea. OLIPASS Corporation was founded in 2006 and is headquartered in Yongin, south Korea. Olipass is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about OLIPASS performance evaluation
Checking the ongoing alerts about OLIPASS for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for OLIPASS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| OLIPASS generated a negative expected return over the last 90 days | |
| OLIPASS has high historical volatility and very poor performance | |
| The company reported the revenue of 851.78 M. Net Loss for the year was (25.72 B) with profit before overhead, payroll, taxes, and interest of 1.81 B. | |
| OLIPASS has accumulated about 8.66 B in cash with (19.62 B) of positive cash flow from operations. | |
| Roughly 35.0% of the company shares are owned by insiders or employees |
- Analyzing OLIPASS's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether OLIPASS's stock is overvalued or undervalued compared to its peers.
- Examining OLIPASS's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating OLIPASS's management team can have a significant impact on its success or failure. Reviewing the track record and experience of OLIPASS's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of OLIPASS's stock. These opinions can provide insight into OLIPASS's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for OLIPASS Stock analysis
When running OLIPASS's price analysis, check to measure OLIPASS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OLIPASS is operating at the current time. Most of OLIPASS's value examination focuses on studying past and present price action to predict the probability of OLIPASS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OLIPASS's price. Additionally, you may evaluate how the addition of OLIPASS to your portfolios can decrease your overall portfolio volatility.
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |